Future Trends in Secondary Myelofibrosis: Market Insights and Epidemiological Forecast to 2032
Secondary Myelofibrosis - Market Insight, Epidemiology, and Market Forecast – 2032
Secondary Myelofibrosis (SMF) is a rare but severe bone marrow disorder that often arises as a progression from other myeloproliferative neoplasms (MPNs) such as polycythemia vera or essential thrombocythemia. Characterized by excessive scarring in the bone marrow, SMF leads to impaired blood cell...